Life Sciences Blog

First in-vitro baby to use DNA sequencing born in the U.S.

Posted on July 9th, by Michael Shapiro-Barr

The first test-tube baby to come from an embryo that used DNA sequencing to screen for genetic defects has been born a healthy boy in the U.S.  The embryo was screened using a new, low-cost technique that could help to improve in-vitro fertilization success rates.  Next-generation sequencing (NGS) allows scientists and doctors to read whole genomes to help in the selection process of embryos to be implanted.

Read More



Comments are closed.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

Navigating the Isolated DNA Patent Eligibility Jungle
Introduction

For over 150 years the Supreme Court has provided three categories of exceptions to patent eligibility under 35 U.S.C §101:  abstract ideas, laws of...

Drug Import Regulation: On the Brink of Historic Change

On Friday, July 12, 2013, the Food and Drug Administration (FDA) hosted a public meeting to discuss the implementation of the drug supply chain...

This Conversation May Be Recorded

As the pharmaceutical industry changes, it must take note of the impact such change has on employee relations and the potential for lawsuits.  Big...